Erdal Cavusoglu, MD

Activated Clotting Time (ACT)-Guided Intravenous Dalteparin Dosing during Percutaneous Coronary Intervention

08/01/2008

The superiority of low-molecular weight heparin (LMWH) over unfractionated heparin (UFH) in the management of acute coronary syndrome (ACS) patients was demonstrated in the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary...

The superiority of low-molecular...

08/01/2008

Journal of Invasive Cardiology

Catheter-induced Spasm of the Left Main Coronary Artery Due to Anatomic ‚ÄúKinking‚Äù in Its Course

08/01/2008

Umesh S. Lingegowda , MD;

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

Catheter-induced spasm of the left main coronary artery is rare but has been previously reported. The accurate diagnosis and differentiation of left main coronary spasm from fixed left main obstructive disease has obvious significant clinical...

Catheter-induced spasm of the...

08/01/2008

Journal of Invasive Cardiology

The Activated Clotting Time (ACT) Can Be Used to Monitor Enoxaparin and Dalteparin after Intravenous Administration

08/01/2008

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

Manish Lakhani , MD;

A major advance in the use of heparin has been the development of low-molecular weight heparins (LMWH), which inhibit both the action (anti-IIa effect) and the generation (anti-Xa effect) of thrombin.1,2 Because of their ease of...

A major advance in the use of...

08/01/2008

Journal of Invasive Cardiology

Case Report

Very Late Bare-Metal Stent Thrombosis. A Case Report and Review of the Literature

08/01/2008

Erdal Cavusoglu , MD;

Ajay Agarwal , MD;

Nagarathna Manjappa , MD;

Stent thrombosis is defined as acute thrombotic occlusion in the stented segment of a coronary artery, usually presenting as ST-segment elevation myocardial infarction,1 and typically occurs within the first several weeks after stent...

Stent thrombosis is defined as...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

High-Dose Tirofiban Administered as Bolus-Only during
Percutaneous Coronary Intervention

08/01/2008

Nagarathna Manjappa , MD;

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

Shyam Poludasu , MD;

Ajay Agarwal , MD;

Inhibition of platelet glycoprotein IIb/IIIa receptors during percutaneous coronary intervention (PCI) using tirofiban, eptifibatide and abciximab has been associated with improved outcomes.1 The only head-to-head comparison to these agents...

Inhibition of platelet...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Impact of Gender on In-Hospital Percutaneous Coronary Interventional Outcomes in African-Americans

08/01/2008

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

Luther T. Clark , MD;

Shyam Poludasu , MD;

Multiple studies have demonstrated that women are at increased risk for in-hospital mortality, stroke, vascular complications, repeat revascularization, and same-admission coronary artery bypass graft surgery (CABG) after percutaneous...

Multiple studies have...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Bolus-Only Platelet Glycoprotein IIb/IIIa Inhibition During Percutaneous Coronary Intervention

08/01/2008

Reuven Lapin , PA-C, PA;

Shyam Poludasu , MD;

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

Pompeiu Vladutiu , MD;

Ajay Agarwal , MD;

Alan Feit , MD;

Several large randomized clinical trials and meta-analyses have shown that inhibition of platelet aggregation with platelet glycoprotein IIb/IIIa inhibitors (GPI) improves outcomes in patients presenting with acute coronary syndromes and in...

Several large randomized...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Effects of Alcoholism on Coronary Artery Disease and Left Ventricular Dysfunction in Male Veterans

08/01/2008

Spyros Kokolis , MD;

Luther T. Clark , MD;

Jonathan D. Marmur , MD, FACC;

John Kassotis , MD;

Erdal Cavusoglu , MD;

Rodamanthos Kokolis , MD;

Reuven Lapin , PA-C, PA;

Sheldon Breitbart , MD;

Jason M. Lazar , MD;

Light-to-moderate alcohol consumption has been associated with a decreased risk of ischemic cardiac events and stroke.1 The cardioprotective effects of alcohol have been attributed to favorable lipid changes, including lower LDL, increased...

Light-to-moderate alcohol...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

A Novel Point-of-Care Assay for the Monitoring of Low-Molecular Weight Heparins in the Cardiac Catheterization Laboratory

09/15/2008

Jonathan D. Marmur , MD, FACC;

Manish Lakhani , MD;

Erdal Cavusoglu , MD;

Soumaya El Rouby , MD;

ABSTRACT: Background. We designed a study to compare the novel point-of-care assay Hemonox clotting time (Hemonox-CT) with the activated clotting time (ACT) and anti-Xa activity to monitor the anticoagulation effects of enoxaparin and...

ABSTRACT: Background. We...

09/15/2008

Journal of Invasive Cardiology

Original Contribution

Impact of Body Mass Index on Long-Term All-Cause Mortality after Percutaneous Coronary Intervention in African-Americans

01/06/2009

Shyam Poludasu , MD;

Waqas Khan , MD;

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

ABSTRACT: Background. Studies on body mass index (BMI) and post-percutaneous coronary intervention (PCI) outcomes have suggested an “obesity paradox” (lower post-PCI mortality rates in obese patients compared to patients of normal weight)....

ABSTRACT: Background. Studies on...

01/06/2009

Journal of Invasive Cardiology